SCHEMBL14155394

SCHEMBL14155394

CC(=O)N1C[C@H](OC(C)(C)C)C[C@H]1C=O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 1/20 0.34
▸ ANPEP P15144 1/20 0.34
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24739167 0.84 NR1H2 (0.40) —
SCHEMBL19198461 0.81 MMP2 (0.40) MMP2ANPEPATM
SCHEMBL16349661 0.77 ATM (0.40) MMP2ANPEPATM
SCHEMBL16316489 0.77 ATM (0.40) MMP2ANPEPATM
SCHEMBL16300658 0.77 ATM (0.40) MMP2ANPEPATM
SCHEMBL14596219 0.75 NR1H2 (0.30) —
SCHEMBL22372628 0.75 — —
SCHEMBL13337538 0.75 — —
SCHEMBL13684693 0.75 — —
SCHEMBL8262943 0.72 NR1H2 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592316-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
EP-1939213-A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-02 — — EP disclosed
Send feedback